Life Sciences Due Diligence Considerations in M&A Transactions Checklist

Summary

This checklist outlines key due diligence considerations for M&A transactions in the U.S. life sciences industry. The "life sciences" sector generally includes pharmaceuticals, biotechnology products, and medical devices. Due diligence in the dynamic and active life sciences industry must query market drivers such as technological progress and innovative therapies; increased competition, particularly in the mid-size and larger pharmaceutical and biotech verticals; and both the push and pull of divestiture and diversification. In this highly regulated industry, due diligence investigations must evolve with the developing regulatory regime.